ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

FY 1984 Bypass Budget Shown By Mechanism,, Research Program

July 2, 1982

NCAB Approves Plan for Public Participation Hearings Around U.S.

February 20, 1987

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006

New Biomedical Research Panel Accepts Broad Mandate. May Suggest Separate Health Dept.

February 28, 1975

Hormone Therapy At Menopause Linked to More Breast Cancer Risk

February 25, 2011

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011